Jim Cramer

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended waiting for DICK'S Sporting Goods, Inc. (NYSE: DKS) stock to come down. "I hate a parabolic move, and that’s exactly what you’re getting there. I don’t like it straight up, so wait," he...

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vertiv Holdings Co (NYSE: VRT) is "one of the great performers of our time." Vertiv is expected to report its fourth quarter results before the opening bell on Feb. 21, 2024. Analysts expect the company to report...

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying The Allstate Corporation (NYSE: ALL), which recently posted upbeat results for its fourth quarter. Cramer's advice comes as Allstate — one of the largest insurance companies in the country —...

After surpassing $45,000, Bitcoin (CRYPTO: BTC) has now soared past the $47,000 mark, marking a 16% increase since Jim Cramer's Jan. 22 tweet that it is "unlikely to find its footing." Analysts see potential for further gains ahead of the halving. What Happened: Bitcoin...

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Freeport-McMoRan Inc. (NYSE: FCX) could go higher by a "couple of points, once the Chinese start manipulating their market higher, but that’s all you’re going to get from them. We have to go higher quality....

Jim Cramer doesn’t have much to say about Digital World Acquisition Corp. (NASDAQ: DWAC). "That’s just kind of a political stock SPAC," he said on CNBC's "Mad Money Lightning Round." Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) is a "...

On CNBC’s "Mad Money Lightning Round," Jim Cramer says Wolfspeed, Inc. (NYSE: WOLF) is "losing too much money" and referred to the semiconductor manufacturer as a "second-rate player." The Durham, N.C.-based company reported second-quarter losses of 55 cents...

On CNBC’s "Mad Money Lightning Round," Jim Cramer believes in GSK plc (NYSE: GSK). "I think GSK is going even higher than it is right now," he said. "It’s been a terrific winner of late." GSK recently resolved a U.S. lawsuit concerning its heartburn...

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Chewy, Inc. (NYSE: CHWY) is fine. "I think it’s very low, and that’s something worth taking a look," he added.  The company's shares have tumbled around 20% over the past month. On Jan. 11,...

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he has always liked Woodward, Inc. (NASDAQ: WWD). Woodward reported better-than-expected first-quarter financial results on Monday. The company posted adjusted earnings of $1.45 per share, beating market estimates of $1.10...

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is taking a "hard pass" on Surgery Partners, Inc. (NASDAQ: SGRY). "That industry has been up and down and up and down," he added. Surgery Partners recently reaffirmed its 2023 adjusted EBITDA guidance...

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is quite fond of John Bean Technologies Corporation (NYSE: JBT). "It’s a little quirky, but it’s good. Global industrial food has always been one of my faves," he added. John Bean Technologies...

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended to buy Constellation Energy Corporation (NASDAQ: CEG). "All the kin of energy that I like under one roof," he added. Constellation Energy, last month, announced the board approved a $1 billion increase to the...

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying BlackRock, Inc. (NYSE: BLK). "I think that was an amazing quarter," he added. The Securities and Exchange Commission (SEC) has postponed the deadline for passing a judgment on the proposed spot...

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is "too risky." Praxis Precision Medicines recently priced its underwritten public offering of 3.17 million shares at $35.50 per share and, in lieu of shares of...